Tackling COVID‐19 Using Remdesivir and Favipiravir as Therapeutic Options-Reference-Cited by-同舟云学术

Tackling COVID‐19 Using Remdesivir and Favipiravir as Therapeutic Options

Published:2020-11-11 Issue:6 Volume:22 Page:939-948
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Sreekanth Reddy Obireddy¹,Lai Wing‐Fu²³

Affiliation:

1. Department of Chemistry Sri Sri Krishnadevaraya University Anantapur 515003 India

2. Ciechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences The Chinese University of Hong Kong (Shenzhen) Shenzhen 518172 P. R. China

3. Department of Applied Biology and Chemical Technology Hong Kong Polytechnic University Hong Kong Special Administrative Region P. R. China

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbic.202000595

Reference90 articles.

1. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

3. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV

4. Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Synergism of Anticancer Action in Combination with Favipiravir and Paclitaxel on Neuroblastoma Cells;Medicina;2023-12-30

2. Quantum DFT studies on the drug delivery of favipiravir using pristine and functionalized chitosan nanoparticles;Scientific Reports;2023-12-11

3. Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1;Scientific Reports;2023-11-17

4. Innovative micellar-UPLC approach for concomitant determination of favipiravir and remdesivir with four co-administered cardiovascular drugs in their pharmaceuticals and spiked plasma: Greenness and whiteness assessment;Microchemical Journal;2023-11

5. Clinical use of antiviral, antibiotic and immunomodulatory drugs in hospitalized COVID-19 patients: a retrospective study in Bandung, Indonesia;F1000Research;2023-07-28